RNA-based Therapeutics
Buy Rating Affirmed for ProQR on Promising RNA Editing Technology and Solid Financial Footing
Antisense and RNAi therapeutics Market Leaders: Profiles and Achievements of Top Companies
Global RNAi Therapeutics Market Analysis Report 2024-2028: Progress in Collaborations & Associated Deals Bodes Well for the Sector
Alnylam Pharmaceuticals
Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q1 2024 Earnings Call Transcript
Buy Recommendation on ProQR’s Innovative RNA Editing Platform and Promising Clinical Prospects
Scientists reveal how SID-1 recognizes dsRNA and initiates systemic RNA interference
Arcturus Therapeutics Announces First Quarter 2024 Financial Update and Pipeline Progress
RNA Nanotechnology
RNA's hidden potential: New study unveils its role in early life and future bioengineering
Nanotechnology News
A promising target for new RNA therapeutics now accessible
Nanoparticle researchers develop microfluidic platform for better delivery of gene therapy for lung disease
Nature Nanotechnology
11 Best Nanotechnology Stocks To Invest In
Nanotechnology in Therapeutics
RNA News and Research
What is nano-texture glass and do I need it?
RNA Vaccines
Moderna announces delay in RSV vaccine review in U.S.
What does science say about mRNA vaccines for pigs?
This new Google AI will help scientist understand human body and create new vaccines for diseases
Sanofi Inks $1.2 Billion Vaccine Licensing Deal With Novavax
RNA
New study discovers cellular activity that hints recycling is in our DNA
Telesis Bio Reports First Quarter 2024 Financial Results